You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAAS

Showing 26 - 50 of 283
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease, Diabetes, Type 2, Hypertension Trial in Genova (Dapagliflozin 10mg Tab, Placebo)

Recruiting
  • Chronic Kidney Disease
  • +2 more
  • Dapagliflozin 10mg Tab
  • Placebo
  • Genova, GE, Italy
    IRCCS Ospedale Policlinico San Martino
Aug 10, 2023

Chronic Kidney Disease(CKD) Trial in Indianapolis (SystemCHANGE (TM), Attention Control)

Enrolling by invitation
  • Chronic Kidney Disease(CKD)
  • SystemCHANGE (TM)
  • Attention Control
  • Indianapolis, Indiana
    Indiana University School of Nursing
Jun 13, 2022

COVID-19 Respiratory Infection, FLU, Cold; Influenza Trial in Kayseri (Kunamin®, Favipiravir, Enoxaparin)

Completed
  • COVID-19 Respiratory Infection
  • +4 more
  • Kunamin®
  • +6 more
  • Kayseri, Kayseri Province, Turkey
    Kayseri City Hospital
Jun 10, 2022

Obesity, Prediabetic State Trial in Boston (Melatonin, Placebo)

Terminated
Has Results
  • Obesity
  • Prediabetic State
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 10, 2021

Menopause, Depression, Heart Disease in Women Trial in Chapel Hill (Trier Social Stress Test)

Recruiting
  • Menopause
  • +3 more
  • Trier Social Stress Test
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Dec 2, 2022

Heart Failure (HF) Trial in Genk (beta blockers, RAAS blockers)

Completed
  • Heart Failure (HF)
  • beta blockers
  • RAAS blockers
  • Genk, Limburg, Belgium
    Ziekenhuis Oost Limburg
Jul 30, 2019

Heart Failure With Reduced Ejection Fraction, Renal Insufficiency Trial in Cairo (Telmisartan)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Renal Insufficiency
  • Cairo, Egypt
    Kasralainy hospital, faculty of medicine, Cairo university
Jul 27, 2021

Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

Recruiting
  • Alport Syndrome
    • Paris, Île-de-France, France
      RaDiCo Eurbio-Alport
    Jun 22, 2023

    Multi-Gene Panel and Renal Denervation Effectiveness in

    Recruiting
    • Hypertension
    • Geneticure for RDN Genetic Panel
    • Dallas, Texas
      Baylor Scott and White Health
    Feb 1, 2022

    Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease Trial (Blood pressure, Urine protein)

    Not yet recruiting
    • Chronic Kidney Disease Stage 2
    • +2 more
    • Blood pressure
    • Urine protein
    • (no location specified)
    Dec 23, 2021

    Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Enrolling by invitation
    • Chronic Kidney Diseases
    • Aurora, Colorado
    • +5 more
    Oct 18, 2022

    Healthy, Pre Hypertension Trial in Birmingham (other, dietary supplement, drug)

    Recruiting
    • Healthy
    • Pre Hypertension
    • Exercise capacity VO2 max determination
    • +3 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 7, 2022

    Diabetic Retinopathy Trial in Birmingham (Diabetic Patients, Healthy Controls)

    Active, not recruiting
    • Diabetic Retinopathy
    • Diabetic Patients
    • Healthy Controls
    • Birmingham, Alabama
      University of Alabama
    Aug 11, 2022

    Functional Mitral Regurgitation Trial in Guangzhou (Dapagliflozin, guideline-directed medical therapy (GDMT))

    Recruiting
    • Functional Mitral Regurgitation
    • Guangzhou, Guangdong, China
    • +2 more
    Nov 4, 2022

    Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Tadalafil 20Mg Oral Tablet
    • Pentoxifylline 400 MG Oral Tablet
    • (no location specified)
    Aug 2, 2022

    Heart Failure, Ischemic Cardiomyopathy Trial in Roma (Blood sample)

    Active, not recruiting
    • Heart Failure
    • Ischemic Cardiomyopathy
    • Blood sample
    • Roma, Italy
      Fondazione Policlinico Gemelli
    Feb 27, 2023

    Lung Injury in COVID-19: Treatment With Furosemide and Negative

    Completed
    • COVID-19
      • Mar del Plata, Buenos Aires, Argentina
        Clínica Colón
      Apr 20, 2022

      HIV Trial in Boston (Eplerenone, Placebo, Lifestyle Modification)

      Completed
      • HIV
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jul 14, 2022

      PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo

      Recruiting
      • PreDiabetes
      • +3 more
      • Sacubitril-Valsartan Tab 97-103 MG
      • +2 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Jul 21, 2022

      Type 2 Diabetes, Hypertension Trial in New Orleans (Dapagliflozin, Sulfonylurea, Placebo)

      Completed
      Has Results
      • Type 2 Diabetes
      • Hypertension
      • New Orleans, Louisiana
        Tulane University
      Oct 5, 2022

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

      Not yet recruiting
      • Type 1 Diabetes Mellitus With Diabetic Nephropathy
      • Aurora, Colorado
      • +6 more
      Oct 2, 2023

      Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)

      Recruiting
      • Chronic Hepatitis b
      • +5 more
      • Empagliflozin 10 MG
      • Placebo pills
      • Hong Kong, Hong Kong, China, Hong Kong
        The University of Hong Kong/Queen Mary Hospital
      May 31, 2022

      Heart Failure Trial (Dapagliflozin 10mg Tab)

      Not yet recruiting
      • Heart Failure
      • Dapagliflozin 10mg Tab
      • (no location specified)
      Feb 14, 2023

      SGLT-2 Inhibitors in the Treatment of Ascites

      Recruiting
      • Ascites Hepatic
      • +2 more
      • SGLT2 inhibitor
      • Palermo, Italy
      • +1 more
      Aug 11, 2023